Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,051,460
  • Shares Outstanding, K 85,281
  • Annual Sales, $ 2,707 M
  • Annual Income, $ 581,780 K
  • 60-Month Beta 0.90
  • Price/Sales 21.92
  • Price/Cash Flow 87.54
  • Price/Book 83.28
Trade IDXX with:

Options Overview

Details
  • Implied Volatility 26.73%
  • Historical Volatility 24.69%
  • IV Percentile 13%
  • IV Rank 20.84%
  • IV High 46.19% on 10/28/20
  • IV Low 21.60% on 06/11/21
  • Put/Call Vol Ratio 2.44
  • Today's Volume 213
  • Volume Avg (30-Day) 356
  • Put/Call OI Ratio 1.72
  • Today's Open Interest 6,846
  • Open Int (30-Day) 7,634

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 2.01
  • Number of Estimates 5
  • High Estimate 2.17
  • Low Estimate 1.90
  • Prior Year 1.72
  • Growth Rate Est. (year over year) +16.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
627.23 +6.54%
on 07/01/21
706.95 -5.47%
on 07/29/21
+36.71 (+5.81%)
since 06/30/21
3-Month
507.66 +31.64%
on 05/12/21
706.95 -5.47%
on 07/29/21
+119.27 (+21.73%)
since 04/30/21
52-Week
347.54 +92.28%
on 09/18/20
706.95 -5.47%
on 07/29/21
+294.16 (+78.63%)
since 07/30/20

Most Recent Stories

More News
IDEXX (IDXX) Q2 Earnings Beat Estimates, 2021 Guidance Up

Strength in CAG Diagnostics and Water businesses drove IDEXX's (IDXX) second-quarter revenues.

BSX : 45.58 (+0.57%)
LH : 297.50 (+0.96%)
IDXX : 669.02 (-4.99%)
WST : 408.85 (+0.97%)
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 16.42% and 5.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

IDXX : 669.02 (-4.99%)
Idexx: Q2 Earnings Snapshot

WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported second-quarter profit of $202.6 million.

IDXX : 669.02 (-4.99%)
IDEXX Laboratories Announces Second Quarter Results

July 30, 2021 /PRNewswire/ --

IDXX : 669.02 (-4.99%)
Why IDEXX Laboratories (IDXX) Might Surprise This Earnings Season

IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

IDXX : 669.02 (-4.99%)
Should JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) Be on Your Investing Radar?

Style Box ETF report for JPME

JPME : 89.42 (+0.20%)
DVN : 25.91 (-2.70%)
IDXX : 669.02 (-4.99%)
FTNT : 266.99 (-2.63%)
IJH : 270.12 (unch)
VO : 240.62 (-0.27%)
What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

IDEXX's (IDXX) fiscal second-quarter top line is expected to have benefited from strength in CAG and LPD businesses.

LH : 297.50 (+0.96%)
HSIC : 79.99 (-0.29%)
IDXX : 669.02 (-4.99%)
HRC : 136.25 (-0.45%)
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IDXX : 669.02 (-4.99%)
Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

IDXX : 669.02 (-4.99%)
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

IDXX : 669.02 (-4.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff...

See More

Key Turning Points

3rd Resistance Point 724.64
2nd Resistance Point 715.79
1st Resistance Point 709.98
Last Price 669.02
1st Support Level 695.32
2nd Support Level 686.47
3rd Support Level 680.66

See More

52-Week High 706.95
Last Price 669.02
Fibonacci 61.8% 569.66
Fibonacci 50% 527.24
Fibonacci 38.2% 484.83
52-Week Low 347.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar